Responsive image

Common name


2-ethyl-4-phenyl-1,2,4-triazol-3-one

IUPAC name


2-ethyl-4-phenyl-1,2,4-triazol-3-one

SMILES


O=c1n(cnn1CC)c2ccccc2

Common name


2-ethyl-4-phenyl-1,2,4-triazol-3-one

IUPAC name


2-ethyl-4-phenyl-1,2,4-triazol-3-one

SMILES


O=c1n(cnn1CC)c2ccccc2

INCHI


InChI=1S/C10H11N3O/c1-2-13-10(14)12(8-11-13)9-6-4-3-5-7-9/h3-8H,2H2,1H3

FORMULA


C10H11N3O

Responsive image

Common name


2-ethyl-4-phenyl-1,2,4-triazol-3-one

IUPAC name


2-ethyl-4-phenyl-1,2,4-triazol-3-one





Molecular weight


191.230

clogP


-2.293

clogS


-1.599

Frequency


0.0003





HBond Acceptor


1

HBond Donor


1

Total Polar
Surface Area


32.34

Number of Rings


2

Rotatable Bond


2

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD01013 Itraconazole Responsive image Antifungal Agents; Antiprotozoal Agents; 14-alpha Demethylase Inhibitors; Antiinfectives for Systemic Use; Triazole Derivatives; Antimycotics for Systemic Use; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4mw5_ligand_3_34.mol2 4mw5 0.612903 -7.37 C(C)NC(=O)Nc1ccccc1 12
4mvx_ligand_3_12.mol2 4mvx 0.612903 -7.35 CCNC(=O)Nc1ccccc1 12
4ekg_ligand_3_28.mol2 4ekg 0.612903 -7.24 N(C(=O)NCC)c1ccccc1 12
4eki_ligand_3_36.mol2 4eki 0.612903 -7.20 N(C(=O)NCC)c1ccccc1 12
4wvl_ligand_3_14.mol2 4wvl 0.612903 -6.94 O=C(Nc1ccccc1)NCC 12
4mx1_ligand_3_9.mol2 4mx1 0.612903 -6.70 O=C(NCC)Nc1ccccc1 12
4ngs_ligand_3_7.mol2 4ngs 0.612903 -6.65 O=C(NCC)Nc1ccccc1 12
100 , 11